AKRX News and Press, Akorn Inc. From 07/11/19

LAKE FOREST, Ill., July 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, August 1, 2019 outlining its second quarter 2019 financi...

LAKE FOREST, Ill., June 28, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it has launched its first-to-market generic of Loteprednol Etabonate Ophthalmic Suspension, 0.5%. Douglas Boothe, Akorn’s P...

Acer Therapeutics (NASDAQ: ACER )  -79%  after FDA rejects Edsivo application for rare connective tissue disorder. More news on: Acer Therapeutics Inc., Cemtrex, Inc., Aldeyra Therapeutics, Inc., Stocks on the move, Read more ...

LAKE FOREST, Ill., June 25, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter from the U.S. Food and Drug Administration (FDA) related to the inspection of its Somerset, New Jersey manufacturi...

Teva Pharmaceutical Industries ( TEVA -4.2% ) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the continued erosion of Copaxone sales (down 56% in Q1) and its potential exposure from opioid ...

Gainers: AMBA   +14.2% . COLD   +3.9% . HQY   +3.8% . CRM   +1.7% . AKRX   +1.4% . More news on: Ambarella, Inc., Americold Realty Trust, HealthEquity, Inc., Stocks on the move, Read more ...

LAKE FOREST, Ill., May 30, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that management will present at the Jefferies 2019 Global Healthcare Conference on Friday, June 7, 2019 at 9:30 a.m. EDT in New York, NY. A l...

The FDA approves Akorn's (NASDAQ: AKRX ) Azelastine Hydrochloride Nasal Spray, 0.1%, a generic version of Moda's Astepro for the treatment of seasonal allergic rhinitis. More news on: Akorn, Inc., Healthcare stocks news, Stocks on the move, Read more ...

LAKE FOREST, Ill., May 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Azelastine Hy...

LAKE FOREST, Ill., May 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that management will present at the 2019 RBC Capital Markets Healthcare Conference on Wednesday, May 22, 2019 at 2:05 p.m. EDT in New York...